ALPS Advisors’s ACELYRIN SLRN Stock Holding History

ALPS Advisors’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-74,640	Closed	-$184K	–	1057
2025 Q1	$184K	Sell	74,640 -6,489	-8%	-$15.4K	﹤0.01%	966
2024 Q4	$255K	Buy	81,129 +3,883	+5%	+$18.8K	﹤0.01%	954
2024 Q3	$381K	Sell	77,246 -4	-0%	-$21	﹤0.01%	685
2024 Q2	$341K	Buy	77,250 +8,591	+13%	+$40.3K	﹤0.01%	763
2024 Q1	$463K	Buy	68,659 +4,032	+6%	+$30.6K	﹤0.01%	600
2023 Q4	$482K	Buy	+64,627	New	+$552K	﹤0.01%	610

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ALPS Advisors's SLRN Position: Q2 2025 in Review

ALPS Advisors sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 74,640 shares — an estimated $184K sold.

ALPS Advisors first reported a position in SLRN in Q4 2023 and held it in 6 quarters. The position peaked at $482K in Q4 2023. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

ALPS Advisors reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
ALPS Advisors sold 74,640 ACELYRIN shares in Q2 2025, an estimated $184K.
ALPS Advisors first reported a position in ACELYRIN in Q4 2023 and held it in 6 quarters.
ALPS Advisors's ACELYRIN position peaked at $482K in Q4 2023.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on ALPS Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.